About the job

Key Responsibilities:

Analyse pharma market to identify gaps and opportunities, especially in the innovative space

Prepare market performance overview for Glenmark’s competition for all dosage forms

Generate ideas of high value for proprietary products for Glenmark for global markets

Evaluate new unique opportunities using multiple databases and recommend potential additions to the portfolio

Conduct risk assessments of the existing portfolio with suitable mitigation strategies.

Prepare business cases using standard forecasting tools for investments in product or portfolio acquisition with inputs from business and Product Development teams for in-house and in-licensed assets

Support the regional portfolio leads in preparing product grids for next five years with high potential peak Sale factoring in complexity of various stakeholders like R&D, RA, Manufacturing, Clinical and IP.

Ensure the selected grid remains relevant and in good standing through regular reviews.

Knowledge and Skills

Forecasting for NCE, generic, differentiated generic products

Ability to incorporate qualitative inputs into quantitative models

Understanding of market access, reimbursement, competitive environment in major markets

Portfolio experience & Strong medical knowledge in various therapy areas specially in Dermatology, Respiratory and Oncology

Strong communication, negotiation and influencing skills. Strong in business analytics and planning for short and medium term

Good understanding of business operations management

Identification of new innovative/specialty/505(b)2 opportunities

Optional : Understanding of current regulatory processes for relevant markets

Understanding of IP issues in pharmaceuticals including Hatch-Waxmann

Strong CMC knowledge for various dosage form including oral solids, injectable, dermatology.

Interested candidates can apply by sending their resume and application form to Sagar.Goswami@glenmarkpharma.com with subject line as “Application for Head – Analytics & Competitive Intelligence ” latest by 14th February 2025